This white paper explores the value of taking a fresh approach to clinical data management, its associated systems and ultimately the processes and roles that surround them. With the right technologies in place, companies can re-invent the traditional roles of Clinical Research Associates (CRAs) and Data Managers to reduce trial costs and timelines.
Ideally, in what could be considered “Clinical Trials 2.0”, trial sponsors will have the benefit of one integrated platform used to collect, review, and share relevant data from site systems, patient-home systems and other external sources.
